COMMUNIQUÉS West-GlobeNewswire
-
Opthea Reports Full-Year Financial Results and Business Updates
30/08/2024 - 13:30 -
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
30/08/2024 - 13:00 -
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
30/08/2024 - 13:00 -
Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC
30/08/2024 - 13:00 -
Trading by management and close relations of management
30/08/2024 - 12:17 -
BioConnection appoints Dr. Gary M. Phillips as new Chairman of its Supervisory Board
30/08/2024 - 10:43 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
30/08/2024 - 10:39 -
HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China
30/08/2024 - 06:30 -
Raw Garden Announces End of Summer and Labor Day Deals
30/08/2024 - 02:50 -
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
30/08/2024 - 01:32 -
Le KFSHRC conclut sa participation à la conférence AMEE 2024 en Suisse
30/08/2024 - 01:17 -
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 (ibudilast) for the Post-COVID Condition
30/08/2024 - 01:00 -
Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions
30/08/2024 - 00:53 -
ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q2 FINANCIAL RESULTS AND NEW OPPORTUNITIES
29/08/2024 - 23:44 -
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
29/08/2024 - 22:50 -
Ultragenyx to Participate in Investor Conferences in September
29/08/2024 - 22:30 -
Umoja Biopharma to Participate in Upcoming Investor Conferences in September
29/08/2024 - 22:30 -
StateHouse Reports Second Quarter 2024 Financial Results
29/08/2024 - 22:30 -
WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters’ Over-Allotment Option
29/08/2024 - 22:30
Pages